Showing 221-230 of 3171 results for "".
Skin of Color Society in NYC; Highlights from 2017
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-skin-of-color-society-in-nyc-highlights-from-2017/18359/In this special edition of DermWireTV, Seemal Desai, MD offers a recap of the Skin of Color Society's media day in New York. Plus, a look at the most-read and viewed content from Practical Dermatology® magazine and DermTube.com, featuring Heidi Waldorf, MD, Linda Stein-Gold, MD, Ted Rosen, MD, JoelBipolar Radiofrequency Microneedling for the Treatment of Facial Lipoma: A Case Study
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/bipolar-radiofrequency-microneedling-for-the-treatment-of-facial-lipoma-a-case-study/24001/Clara Barranco, MD, Rachel Murray, DO, Karthik Krishnamurthy, DO, Alexandra Lawlor BS, and Mary Pentel, MDScientifically Speaking: Updated Approaches to Surgical/Aesthetic Patient Safety
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-updated-approaches-to-surgicalaesthetic-patient-safety/19905/From antiseptics to eye shields, a panel of experts weighs in what you should be doing in your surgical and aesthetic practice to support patient and physician safety. Host Joel L. Cohen, MD leads the conversation with Mathew Avram, MD, JD; Brian Biesman, MD; Suzanne Kilmer, MD; and Christopher ZachApproval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by healAll About Acne in 2017
https://practicaldermatology.com/topics/psoriasis/all-about-acne-in-2017/20777/Dermatologist Linda Stein Gold, MD discusses new directions in acne treatment.Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uEffector Cell Response Inhibitors
https://practicaldermatology.com/series/c-suite-chats/effector-cell-response-inhibitors/48960/Excellergy cofounder Alexander Eggel, PhD, and CEO Todd Zavodnick discuss a recent Journal of Allergy and Clinical Immunology article validating the trifunctional mechanism of action of effector cell response inhibitors (ECRIs) for the treatment of allergic diseases, including chronic spontaneous urEffector Cell Response Inhibitors
https://practicaldermatology.com/series/c-suite-chats/effector-cell-response-inhibitors/48959/Excellergy cofounder Alexander Eggel, PhD, and CEO Todd Zavodnick discuss a recent Journal of Allergy and Clinical Immunology article validating the trifunctional mechanism of action of effector cell response inhibitors (ECRIs) for the treatment of allergic diseases, including chronic spontaneous urWomen in Dermatology: Melissa Kanchanapoomi Levin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-melissa-kanchanapoomi-levin-md/23063/AI-based DermGPT Focuses on Improved Clinic Productivity
https://practicaldermatology.com/topics/practice-management/ai-based-dermgpt-focuses-on-improved-clinic-productivity/23990/With Faranak Kamangar, MD; an interview by Heidi W. Moore